Memorial Sloan Kettering Cancer Center

This study tested whether the drug romiplostim can help prevent dangerously low platelet counts caused by chemotherapy in lymphoma patients. Eleven adults with lymphoma received romiplostim alongside their chemo to see if it could reduce the need for treatment delays, lower chemo…

This study tested two radiation methods for people with cancer that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). One method, proton craniospinal radiation, treats the entire fluid-filled space around the brain and spine. The other, partial ph…

This study tested a combination of two drugs, talazoparib and temozolomide, in 16 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to find the safest dose and see if the drugs could shrink tumors. The treatment is not a cure, but aims to …

This early-stage study tested the safety of combining different doses of external radiation therapy with the chemotherapy drug gemcitabine in 19 adults with bladder cancer that had not spread. The goal was to find the highest safe radiation dose and see how well the treatment wor…

This early-phase trial tested a combination of two drugs (vemurafenib and copanlisib) in 8 people with advanced thyroid cancer that had stopped responding to standard radioiodine therapy. The goal was to see if the drug combo could make the cancer sensitive to radioiodine again, …

This study tested whether adding the drug pembrolizumab to standard radiation or ablation could help control metastatic colorectal cancer. The idea was that the combination might boost the immune system to attack tumors that were not directly treated. 34 people who had already tr…

This study tested whether family therapy, given while a person is being treated for advanced cancer, helps families communicate and support each other during and after the patient's death. 700 families were randomly assigned to standard care, 6 therapy sessions, or 10 therapy ses…

This study looked at two ways to help older patients (65+) with head and neck cancer manage side effects during radiation and chemotherapy. Researchers compared a special geriatric care team approach with standard supportive care. The goal was to see which method reduces hospital…

This early-stage study tested a new dye called Illuminare-1 that makes nerves glow during prostate cancer surgery. The goal was to help surgeons avoid damaging nerves, which can cause side effects like incontinence and erectile dysfunction. 41 men undergoing prostate removal took…

This study tested if a special dye (ICG) can help surgeons find the first lymph nodes that drain from the ovary during surgery. 48 women having surgery for an ovarian mass or to lower their cancer risk took part. The goal was to see how well the dye works, not to treat the diseas…

This study asked 41 stem cell transplant patients and their caregivers what they thought about a set of coping skills manuals called "Coping Together." The goal was to see if the manuals were helpful and to get suggestions for improvement. The study did not test a treatment, but …

This study looked at whether screening cancer caregivers for distress and providing targeted support (the S+C approach) is better than usual care. About 150 caregivers of cancer patients took part. The goal was to see if this approach reduces caregivers' unmet needs and improves …